首页> 外国专利> A method of inducing antitumor cytotoxic immunity by dendritic cells transfected with RNA TUMOR CELLS AGAINST BREAST CANCER CELLS

A method of inducing antitumor cytotoxic immunity by dendritic cells transfected with RNA TUMOR CELLS AGAINST BREAST CANCER CELLS

机译:通过用RNA肿瘤细胞转染抗乳腺癌细胞的树突状细胞诱导抗肿瘤细胞毒性免疫的方法

摘要

A method of inducing an antitumor cytotoxic immune response using dendritic cells transfected with RNA of tumor cells against breast cancer cells (breast cancer), comprising co-culturing autologous mononuclear cells (MNC) isolated from peripheral blood dendritic cells (DC) derived from the monocytes adhering MNC fraction of tumor cells transfected with RNA and then exposed to TNF-α stimulated maturation, characterized in that the non-stick cocultivation RAC IOCs and DCs transfected with RNA of autologous tumor cells is performed in the presence of recombinant human interleukin -12 and - recombinant human interleukin -18, and to obtain mature DC after two days of culturing adherent fraction MNC patients with breast cancer received immature DCs transfected with tumor RNA after day stimulated subjected to maturation for a further day.
机译:一种使用转染有肿瘤细胞RNA的树突状细胞针对乳腺癌细胞(乳腺癌)诱导抗肿瘤细胞毒性免疫反应的方法,该方法包括共培养从单核细胞衍生的外周血树突状细胞(DC)中分离的自体单核细胞(MNC)转染RNA,然后暴露于TNF-α刺激的成熟细胞的黏附MNC组分,其特征在于,在重组人白介素-12和TNF-α存在下进行自粘肿瘤细胞RNA转染的不粘共培养RAC IOC和DC。 -重组人白介素-18,并且在培养粘附分数的MNC乳腺癌患者两天后培养以获得成熟的DC,在刺激的第二天将其成熟后,将未成熟的DC经肿瘤RNA转染,然后再进行成熟。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号